1	4	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Discussion	_	_	NN	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	found	_	_	VBD	_	_	_	_	_
3	bilateral	_	_	JJ	_	_	_	_	_
4	hypersensitivity	_	_	NN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	pressure	_	_	NN	_	_	_	_	_
7	pain	_	_	NN	_	_	_	_	_
8	within	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	temporalis	_	_	NN	_	_	_	_	_
11	muscle	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	men	_	_	NNS	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	episodic	_	_	JJ	_	_	_	_	_
16	CH	_	_	NN	_	_	_	_	_
17	not	_	_	RB	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	be	_	_	VB	_	_	_	_	_
20	associated	_	_	VBN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	levels	_	_	NNS	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	anxiety	_	_	NN	_	_	_	_	_
25	or	_	_	CC	_	_	_	_	_
26	depression	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Additionally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	our	_	_	PRP$	_	_	_	_	_
4	mapping	_	_	NN	_	_	_	_	_
5	revealed	_	_	VBD	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	spatial	_	_	JJ	_	_	_	_	_
8	anterior-to-posterior	_	_	JJ	_	_	_	_	_
9	gradient	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	sensitivity	_	_	NN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	pressure	_	_	NN	_	_	_	_	_
14	pain	_	_	NN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	men	_	_	NNS	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	CH	_	_	NN	_	_	_	_	_
19	but	_	_	CC	_	_	_	_	_
20	not	_	_	RB	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	headache-free	_	_	JJ	_	_	_	_	_
23	controls	_	_	NNS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	line	_	_	NN	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	our	_	_	PRP$	_	_	_	_	_
5	hypothesis	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	there	_	_	EX	_	_	_	_	_
8	was	_	_	VBD	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	bilateral	_	_	JJ	_	_	_	_	_
11	decrease	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	PPTs	_	_	NNS	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	men	_	_	NNS	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	CH	_	_	NNP	_	_	_	_	_
18	compared	_	_	VBN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	controls	_	_	NNS	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	large	_	_	JJ	_	_	_	_	_
23	effect	_	_	NN	_	_	_	_	_
24	sizes	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Our	_	_	PRP$	_	_	_	_	_
2	results	_	_	NNS	_	_	_	_	_
3	agree	_	_	VBP	_	_	_	_	_
4	with	_	_	IN	_	_	_	_	_
5	those	_	_	DT	_	_	_	_	_
6	previously	_	_	RB	_	_	_	_	_
7	reported	_	_	VBD	_	_	_	_	_
8	where	_	_	WRB	_	_	_	_	_
9	bilateral	_	_	JJ	_	_	_	_	_
10	hypersensitivity	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	pain	_	_	NN	_	_	_	_	_
13	pressure	_	_	NN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	temporalis	_	_	NN	_	_	_	_	_
17	area	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	patients	_	_	NNS	_	_	_	_	_
20	with	_	_	IN	_	_	_	_	_
21	CH	_	_	NNP	_	_	_	_	_
22	was	_	_	VBD	_	_	_	_	_
23	also	_	_	RB	_	_	_	_	_
24	observed	_	_	VBN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	results	_	_	NNS	_	_	_	_	_
5	differ	_	_	VBP	_	_	_	_	_
6	from	_	_	IN	_	_	_	_	_
7	those	_	_	DT	_	_	_	_	_
8	reported	_	_	VBN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	Malo-Urri√©s	_	_	NNP	_	_	_	_	_
11	et	_	_	FW	_	_	_	_	_
12	al.	_	_	FW	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	who	_	_	WP	_	_	_	_	_
15	observed	_	_	VBD	_	_	_	_	_
16	that	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	symptomatic	_	_	JJ	_	_	_	_	_
19	side	_	_	NN	_	_	_	_	_
20	was	_	_	VBD	_	_	_	_	_
21	more	_	_	RBR	_	_	_	_	_
22	sensitive	_	_	JJ	_	_	_	_	_
23	than	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	non-symptomatic	_	_	JJ	_	_	_	_	_
26	side	_	_	NN	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	small	_	_	JJ	_	_	_	_	_
30	sample	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	patients	_	_	NNS	_	_	_	_	_
33	with	_	_	IN	_	_	_	_	_
34	CH	_	_	NNP	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	current	_	_	JJ	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	previous	_	_	JJ	_	_	_	_	_
5	findings	_	_	NNS	_	_	_	_	_
6	suggest	_	_	VBP	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	presence	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	sensitization	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	trigeminal	_	_	JJ	_	_	_	_	_
13	pain	_	_	NN	_	_	_	_	_
14	pathways	_	_	NNS	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	CH	_	_	NN	_	_	_	_	_
17	patients	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	presence	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	bilateral	_	_	JJ	_	_	_	_	_
8	pressure	_	_	NN	_	_	_	_	_
9	pain	_	_	NN	_	_	_	_	_
10	hyperalgesia	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	patients	_	_	NNS	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	unilateral	_	_	JJ	_	_	_	_	_
15	symptoms	_	_	NNS	_	_	_	_	_
16	supports	_	_	VBZ	_	_	_	_	_
17	potential	_	_	JJ	_	_	_	_	_
18	sensitization	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	central	_	_	JJ	_	_	_	_	_
22	nervous	_	_	JJ	_	_	_	_	_
23	system	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	as	_	_	IN	_	_	_	_	_
26	previously	_	_	RB	_	_	_	_	_
27	suggested	_	_	VBN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	although	_	_	IN	_	_	_	_	_
30	further	_	_	JJR	_	_	_	_	_
31	studies	_	_	NNS	_	_	_	_	_
32	are	_	_	VBP	_	_	_	_	_
33	needed	_	_	VBN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Similarly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	bilateral	_	_	JJ	_	_	_	_	_
4	hyperalgesia	_	_	NN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	pressure	_	_	NN	_	_	_	_	_
7	over	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	temporalis	_	_	NN	_	_	_	_	_
10	muscle	_	_	NN	_	_	_	_	_
11	has	_	_	VBZ	_	_	_	_	_
12	previously	_	_	RB	_	_	_	_	_
13	been	_	_	VBN	_	_	_	_	_
14	found	_	_	VBN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	patients	_	_	NNS	_	_	_	_	_
17	with	_	_	IN	_	_	_	_	_
18	strictly	_	_	RB	_	_	_	_	_
19	unilateral	_	_	JJ	_	_	_	_	_
20	migraine	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	suggesting	_	_	VBG	_	_	_	_	_
23	that	_	_	IN	_	_	_	_	_
24	bilateral	_	_	JJ	_	_	_	_	_
25	hypersensitivity	_	_	NN	_	_	_	_	_
26	is	_	_	VBZ	_	_	_	_	_
27	present	_	_	JJ	_	_	_	_	_
28	albeit	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	presence	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	just	_	_	RB	_	_	_	_	_
33	unilateral	_	_	JJ	_	_	_	_	_
34	symptoms	_	_	NNS	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	individuals	_	_	NNS	_	_	_	_	_
37	with	_	_	IN	_	_	_	_	_
38	primary	_	_	JJ	_	_	_	_	_
39	headaches	_	_	NNS	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Our	_	_	PRP$	_	_	_	_	_
2	patients	_	_	NNS	_	_	_	_	_
3	were	_	_	VBD	_	_	_	_	_
4	assessed	_	_	VBN	_	_	_	_	_
5	during	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	long-lasting	_	_	JJ	_	_	_	_	_
8	remission	_	_	NN	_	_	_	_	_
9	phase	_	_	NN	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	pressure	_	_	NN	_	_	_	_	_
4	pain	_	_	NN	_	_	_	_	_
5	hyperalgesia	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	trigeminal	_	_	JJ	_	_	_	_	_
9	area	_	_	NN	_	_	_	_	_
10	seems	_	_	VBZ	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	present	_	_	JJ	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	patients	_	_	NNS	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	CH	_	_	NN	_	_	_	_	_
18	during	_	_	IN	_	_	_	_	_
19	asymptomatic	_	_	JJ	_	_	_	_	_
20	periods	_	_	NNS	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	findings	_	_	NNS	_	_	_	_	_
3	indicate	_	_	VBP	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	there	_	_	EX	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	baseline	_	_	JJ	_	_	_	_	_
9	state	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	trigeminal	_	_	JJ	_	_	_	_	_
12	sensitization	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	CH	_	_	NN	_	_	_	_	_
15	predisposing	_	_	VBG	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	periods	_	_	NNS	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	pain	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Alternatively	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	it	_	_	PRP	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	also	_	_	RB	_	_	_	_	_
6	possible	_	_	JJ	_	_	_	_	_
7	that	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	altered	_	_	VBN	_	_	_	_	_
10	nociceptive	_	_	JJ	_	_	_	_	_
11	processing	_	_	NN	_	_	_	_	_
12	could	_	_	MD	_	_	_	_	_
13	be	_	_	VB	_	_	_	_	_
14	induced	_	_	VBN	_	_	_	_	_
15	by	_	_	IN	_	_	_	_	_
16	repetitive	_	_	JJ	_	_	_	_	_
17	headache	_	_	NN	_	_	_	_	_
18	attacks	_	_	NNS	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	high	_	_	JJ	_	_	_	_	_
21	intensity	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	then	_	_	RB	_	_	_	_	_
24	maintained	_	_	VBN	_	_	_	_	_
25	without	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	presence	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	any	_	_	DT	_	_	_	_	_
30	nociceptive	_	_	JJ	_	_	_	_	_
31	stimuli	_	_	NNS	_	_	_	_	_
32	during	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	remission	_	_	NN	_	_	_	_	_
35	phase	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Indeed	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	occurrence	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	long-term	_	_	JJ	_	_	_	_	_
7	potentiation	_	_	NN	_	_	_	_	_
8	induced	_	_	VBN	_	_	_	_	_
9	by	_	_	IN	_	_	_	_	_
10	nociceptive	_	_	JJ	_	_	_	_	_
11	stimuli	_	_	NNS	_	_	_	_	_
12	has	_	_	VBZ	_	_	_	_	_
13	been	_	_	VBN	_	_	_	_	_
14	suggested	_	_	VBN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	other	_	_	JJ	_	_	_	_	_
17	primary	_	_	JJ	_	_	_	_	_
18	headaches	_	_	NNS	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	cannot	_	_	MD	_	_	_	_	_
5	confirm	_	_	VB	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	presence	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	central	_	_	JJ	_	_	_	_	_
10	sensitization	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	CH	_	_	NNP	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	since	_	_	IN	_	_	_	_	_
15	PPTs	_	_	NNP	_	_	_	_	_
16	represent	_	_	VBP	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	static	_	_	JJ	_	_	_	_	_
19	outcome	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	dynamic	_	_	JJ	_	_	_	_	_
22	measures	_	_	NNS	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	nociception	_	_	NN	_	_	_	_	_
25	would	_	_	MD	_	_	_	_	_
26	be	_	_	VB	_	_	_	_	_
27	needed	_	_	VBN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Pressure	_	_	NN	_	_	_	_	_
2	pain	_	_	NN	_	_	_	_	_
3	sensitivity	_	_	NN	_	_	_	_	_
4	mapping	_	_	NN	_	_	_	_	_
5	based	_	_	VBN	_	_	_	_	_
6	on	_	_	IN	_	_	_	_	_
7	multi-site	_	_	JJ	_	_	_	_	_
8	recordings	_	_	NNS	_	_	_	_	_
9	has	_	_	VBZ	_	_	_	_	_
10	previously	_	_	RB	_	_	_	_	_
11	been	_	_	VBN	_	_	_	_	_
12	documented	_	_	VBN	_	_	_	_	_
13	as	_	_	IN	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	useful	_	_	JJ	_	_	_	_	_
16	technique	_	_	NN	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	visualizing	_	_	VBG	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	spatial	_	_	JJ	_	_	_	_	_
21	topographic	_	_	JJ	_	_	_	_	_
22	distribution	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	pain	_	_	NN	_	_	_	_	_
25	sensitivity	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	study	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	first	_	_	JJ	_	_	_	_	_
6	attempt	_	_	NN	_	_	_	_	_
7	at	_	_	IN	_	_	_	_	_
8	assessing	_	_	VBG	_	_	_	_	_
9	topographical	_	_	JJ	_	_	_	_	_
10	pressure	_	_	NN	_	_	_	_	_
11	pain	_	_	NN	_	_	_	_	_
12	sensitivity	_	_	NN	_	_	_	_	_
13	maps	_	_	NNS	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	patients	_	_	NNS	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	episodic	_	_	JJ	_	_	_	_	_
18	CH	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	According	_	_	VBG	_	_	_	_	_
2	to	_	_	TO	_	_	_	_	_
3	our	_	_	PRP$	_	_	_	_	_
4	findings	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	CH	_	_	NN	_	_	_	_	_
8	patients	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	there	_	_	EX	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	an	_	_	DT	_	_	_	_	_
13	anterior-to-posterior	_	_	JJ	_	_	_	_	_
14	gradient	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	sensitivity	_	_	NN	_	_	_	_	_
17	within	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	temporalis	_	_	NN	_	_	_	_	_
20	muscle	_	_	NN	_	_	_	_	_
21	so	_	_	RB	_	_	_	_	_
22	that	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	lowest	_	_	JJS	_	_	_	_	_
25	pain	_	_	NN	_	_	_	_	_
26	thresholds	_	_	NNS	_	_	_	_	_
27	are	_	_	VBP	_	_	_	_	_
28	located	_	_	VBN	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	anterior	_	_	JJ	_	_	_	_	_
32	region	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	muscle	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	gradient	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	not	_	_	RB	_	_	_	_	_
5	present	_	_	JJ	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	headache-free	_	_	JJ	_	_	_	_	_
8	controls	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	where	_	_	WRB	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	most	_	_	RBS	_	_	_	_	_
13	sensitive	_	_	JJ	_	_	_	_	_
14	area	_	_	NN	_	_	_	_	_
15	was	_	_	VBD	_	_	_	_	_
16	located	_	_	VBN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	mid-muscle	_	_	JJ	_	_	_	_	_
20	belly	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	results	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	study	_	_	NN	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	similar	_	_	JJ	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	those	_	_	DT	_	_	_	_	_
10	previously	_	_	RB	_	_	_	_	_
11	described	_	_	VBN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	other	_	_	JJ	_	_	_	_	_
14	primary	_	_	JJ	_	_	_	_	_
15	headaches	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	such	_	_	JJ	_	_	_	_	_
18	as	_	_	IN	_	_	_	_	_
19	tension-type	_	_	NN	_	_	_	_	_
20	headache	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	unilateral	_	_	JJ	_	_	_	_	_
23	migraine	_	_	NN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	determine	_	_	VB	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	mechanisms	_	_	NNS	_	_	_	_	_
5	underlying	_	_	VBG	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	anterior-to-posterior	_	_	JJ	_	_	_	_	_
8	gradient	_	_	NN	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	beyond	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	scope	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	current	_	_	JJ	_	_	_	_	_
16	paper	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	two	_	_	CD	_	_	_	_	_
4	hypotheses	_	_	NNS	_	_	_	_	_
5	can	_	_	MD	_	_	_	_	_
6	be	_	_	VB	_	_	_	_	_
7	stated	_	_	VBN	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_


1	First	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	sensitization	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	trigeminal	_	_	JJ	_	_	_	_	_
6	pathways	_	_	NNS	_	_	_	_	_
7	could	_	_	MD	_	_	_	_	_
8	generate	_	_	VB	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	pressure	_	_	NN	_	_	_	_	_
11	pain	_	_	NN	_	_	_	_	_
12	hyperalgesic	_	_	JJ	_	_	_	_	_
13	pattern	_	_	NN	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	an	_	_	DT	_	_	_	_	_
16	anterior-to-posterior	_	_	JJ	_	_	_	_	_
17	distribution	_	_	NN	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	primary	_	_	JJ	_	_	_	_	_
20	headaches	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	regardless	_	_	RB	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	unilateral	_	_	JJ	_	_	_	_	_
25	or	_	_	CC	_	_	_	_	_
26	bilateral	_	_	JJ	_	_	_	_	_
27	location	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	symptoms	_	_	NNS	_	_	_	_	_
31	or	_	_	CC	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	specific	_	_	JJ	_	_	_	_	_
34	type	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	headache	_	_	NN	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	Secondly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	an	_	_	DT	_	_	_	_	_
4	anterior-to-posterior	_	_	JJ	_	_	_	_	_
5	gradient	_	_	NN	_	_	_	_	_
6	could	_	_	MD	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	also	_	_	RB	_	_	_	_	_
9	related	_	_	VBN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	different	_	_	JJ	_	_	_	_	_
12	distribution	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	muscle	_	_	NN	_	_	_	_	_
15	nociceptors	_	_	NNS	_	_	_	_	_
16	between	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	different	_	_	JJ	_	_	_	_	_
19	areas	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	temporalis	_	_	NN	_	_	_	_	_
23	muscle	_	_	NN	_	_	_	_	_
24	that	_	_	WDT	_	_	_	_	_
25	could	_	_	MD	_	_	_	_	_
26	predispose	_	_	VB	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	headaches	_	_	NNS	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	but	_	_	CC	_	_	_	_	_
31	this	_	_	DT	_	_	_	_	_
32	cannot	_	_	MD	_	_	_	_	_
33	be	_	_	VB	_	_	_	_	_
34	confirmed	_	_	VBN	_	_	_	_	_
35	until	_	_	IN	_	_	_	_	_
36	histological	_	_	JJ	_	_	_	_	_
37	studies	_	_	NNS	_	_	_	_	_
38	are	_	_	VBP	_	_	_	_	_
39	conducted	_	_	VBN	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Additionally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	also	_	_	RB	_	_	_	_	_
5	found	_	_	VBD	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	levels	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	anxiety	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	depression	_	_	NN	_	_	_	_	_
13	do	_	_	VBP	_	_	_	_	_
14	not	_	_	RB	_	_	_	_	_
15	seem	_	_	VB	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	have	_	_	VB	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	significant	_	_	JJ	_	_	_	_	_
20	influence	_	_	NN	_	_	_	_	_
21	on	_	_	IN	_	_	_	_	_
22	pressure	_	_	NN	_	_	_	_	_
23	pain	_	_	NN	_	_	_	_	_
24	hyperalgesia	_	_	NN	_	_	_	_	_
25	within	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	trigeminal	_	_	JJ	_	_	_	_	_
28	area	_	_	NN	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	men	_	_	NNS	_	_	_	_	_
31	with	_	_	IN	_	_	_	_	_
32	episodic	_	_	JJ	_	_	_	_	_
33	CH	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	would	_	_	MD	_	_	_	_	_
3	be	_	_	VB	_	_	_	_	_
4	interesting	_	_	JJ	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	investigate	_	_	VB	_	_	_	_	_
7	other	_	_	JJ	_	_	_	_	_
8	potential	_	_	JJ	_	_	_	_	_
9	psychological	_	_	JJ	_	_	_	_	_
10	factors	_	_	NNS	_	_	_	_	_
11	related	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	observed	_	_	VBN	_	_	_	_	_
15	anterior-to-posterior	_	_	JJ	_	_	_	_	_
16	distribution	_	_	NN	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	sensitivity	_	_	NN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	pressure	_	_	NN	_	_	_	_	_
21	pain	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	primary	_	_	JJ	_	_	_	_	_
24	headaches	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	fact	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	differences	_	_	NNS	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	spatial	_	_	JJ	_	_	_	_	_
8	distribution	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	sensitivity	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	pressure	_	_	NN	_	_	_	_	_
13	pain	_	_	NN	_	_	_	_	_
14	should	_	_	MD	_	_	_	_	_
15	be	_	_	VB	_	_	_	_	_
16	considered	_	_	VBN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	future	_	_	JJ	_	_	_	_	_
19	studies	_	_	NNS	_	_	_	_	_
20	comparing	_	_	VBG	_	_	_	_	_
21	headache	_	_	NN	_	_	_	_	_
22	populations	_	_	NNS	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	headache-free	_	_	JJ	_	_	_	_	_
25	controls	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	since	_	_	IN	_	_	_	_	_
28	taking	_	_	VBG	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	same	_	_	JJ	_	_	_	_	_
31	point	_	_	NN	_	_	_	_	_
32	as	_	_	IN	_	_	_	_	_
33	a	_	_	DT	_	_	_	_	_
34	reference	_	_	NN	_	_	_	_	_
35	could	_	_	MD	_	_	_	_	_
36	be	_	_	VB	_	_	_	_	_
37	biased	_	_	VBN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	changes	_	_	NNS	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	spatial	_	_	JJ	_	_	_	_	_
8	distribution	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	pressure	_	_	NN	_	_	_	_	_
11	pain	_	_	NN	_	_	_	_	_
12	within	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	trigeminal	_	_	JJ	_	_	_	_	_
15	area	_	_	NN	_	_	_	_	_
16	could	_	_	MD	_	_	_	_	_
17	be	_	_	VB	_	_	_	_	_
18	used	_	_	VBN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	monitor	_	_	VB	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	effects	_	_	NNS	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	treatment	_	_	NN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	individuals	_	_	NNS	_	_	_	_	_
27	with	_	_	IN	_	_	_	_	_
28	CH	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	must	_	_	MD	_	_	_	_	_
3	recognize	_	_	VB	_	_	_	_	_
4	some	_	_	DT	_	_	_	_	_
5	limitations	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	our	_	_	PRP$	_	_	_	_	_
8	study	_	_	NN	_	_	_	_	_
9	.	_	_	.	_	_	_	_	_


1	First	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	our	_	_	PRP$	_	_	_	_	_
4	sample	_	_	NN	_	_	_	_	_
5	was	_	_	VBD	_	_	_	_	_
6	only	_	_	RB	_	_	_	_	_
7	comprised	_	_	VBN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	men	_	_	NNS	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	episodic	_	_	JJ	_	_	_	_	_
12	CH	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	remission	_	_	NN	_	_	_	_	_
16	phase	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	cannot	_	_	MD	_	_	_	_	_
5	draw	_	_	VB	_	_	_	_	_
6	conclusions	_	_	NNS	_	_	_	_	_
7	concerning	_	_	VBG	_	_	_	_	_
8	women	_	_	NNS	_	_	_	_	_
9	with	_	_	IN	_	_	_	_	_
10	CH	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	or	_	_	CC	_	_	_	_	_
13	men	_	_	NNS	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	chronic	_	_	JJ	_	_	_	_	_
16	CH	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	or	_	_	CC	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	episodic	_	_	JJ	_	_	_	_	_
21	CH	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	an	_	_	DT	_	_	_	_	_
24	active	_	_	JJ	_	_	_	_	_
25	phase	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Secondly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	depressive	_	_	JJ	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	anxiety	_	_	NN	_	_	_	_	_
6	levels	_	_	NNS	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	our	_	_	PRP$	_	_	_	_	_
9	sample	_	_	NN	_	_	_	_	_
10	were	_	_	VBD	_	_	_	_	_
11	relatively	_	_	RB	_	_	_	_	_
12	low	_	_	JJ	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	thus	_	_	RB	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	their	_	_	PRP$	_	_	_	_	_
17	potential	_	_	JJ	_	_	_	_	_
18	role	_	_	NN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	spatial	_	_	JJ	_	_	_	_	_
21	distribution	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	pressure	_	_	NN	_	_	_	_	_
24	pain	_	_	NN	_	_	_	_	_
25	sensitivity	_	_	NN	_	_	_	_	_
26	should	_	_	MD	_	_	_	_	_
27	be	_	_	VB	_	_	_	_	_
28	considered	_	_	VBN	_	_	_	_	_
29	with	_	_	IN	_	_	_	_	_
30	caution	_	_	NN	_	_	_	_	_
31	at	_	_	IN	_	_	_	_	_
32	this	_	_	DT	_	_	_	_	_
33	stage	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Thirdly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	used	_	_	VBD	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	cross-sectional	_	_	JJ	_	_	_	_	_
7	design	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	which	_	_	WDT	_	_	_	_	_
10	does	_	_	VBZ	_	_	_	_	_
11	not	_	_	RB	_	_	_	_	_
12	permit	_	_	VB	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	determine	_	_	VB	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	cause	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	effect	_	_	NN	_	_	_	_	_
19	relationship	_	_	NN	_	_	_	_	_
20	between	_	_	IN	_	_	_	_	_
21	spatial	_	_	JJ	_	_	_	_	_
22	distribution	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	pressure	_	_	NN	_	_	_	_	_
25	pain	_	_	NN	_	_	_	_	_
26	sensitivity	_	_	NN	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	development	_	_	NN	_	_	_	_	_
30	or	_	_	CC	_	_	_	_	_
31	maintenance	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	CH	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	fact	_	_	NN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	headache-free	_	_	JJ	_	_	_	_	_
7	control	_	_	NN	_	_	_	_	_
8	subjects	_	_	NNS	_	_	_	_	_
9	showed	_	_	VBD	_	_	_	_	_
10	heterogeneous	_	_	JJ	_	_	_	_	_
11	pain	_	_	NN	_	_	_	_	_
12	maps	_	_	NNS	_	_	_	_	_
13	suggests	_	_	VBZ	_	_	_	_	_
14	that	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	anterior-to-posterior	_	_	JJ	_	_	_	_	_
17	gradient	_	_	NN	_	_	_	_	_
18	observed	_	_	VBD	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	men	_	_	NNS	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	CH	_	_	NNP	_	_	_	_	_
23	is	_	_	VBZ	_	_	_	_	_
24	related	_	_	VBN	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	presence	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	pain	_	_	NN	_	_	_	_	_
30	.	_	_	.	_	_	_	_	_


1	Longitudinal	_	_	JJ	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	needed	_	_	VBN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	clarify	_	_	VB	_	_	_	_	_
7	this	_	_	DT	_	_	_	_	_
8	hypothesis	_	_	NN	_	_	_	_	_
9	.	_	_	.	_	_	_	_	_


1	Finally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	we	_	_	PRP	_	_	_	_	_
4	only	_	_	RB	_	_	_	_	_
5	assessed	_	_	VBD	_	_	_	_	_
6	static	_	_	JJ	_	_	_	_	_
7	outcomes	_	_	NNS	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	nociception	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	i.	_	_	FW	_	_	_	_	_
12	e.	_	_	FW	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	PPT	_	_	NNP	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Thus	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	dynamic	_	_	JJ	_	_	_	_	_
4	outcomes	_	_	NNS	_	_	_	_	_
5	such	_	_	JJ	_	_	_	_	_
6	as	_	_	IN	_	_	_	_	_
7	temporal	_	_	JJ	_	_	_	_	_
8	summation	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	wind-up	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	or	_	_	CC	_	_	_	_	_
13	conditioned	_	_	VBN	_	_	_	_	_
14	pain	_	_	NN	_	_	_	_	_
15	modulation	_	_	NN	_	_	_	_	_
16	should	_	_	MD	_	_	_	_	_
17	be	_	_	VB	_	_	_	_	_
18	used	_	_	VBN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	future	_	_	JJ	_	_	_	_	_
21	studies	_	_	NNS	_	_	_	_	_
22	to	_	_	TO	_	_	_	_	_
23	further	_	_	RBR	_	_	_	_	_
24	characterize	_	_	VB	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	presence	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	central	_	_	JJ	_	_	_	_	_
29	sensitization	_	_	NN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	CH	_	_	NNP	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_

